Home > SciBX > Targets & Mechanisms > Heat shock hits muscular dystrophy

SciBX, Targets & Mechanisms

Heat shock hits muscular dystrophy

By Tim Fulmer, Senior Writer

Published on Thursday, May 3, 2012

Australian academics have used N-Gene's BGP-15, a small molecule inducer of Hsp72, to increase muscle strength and survival in mice with muscular dystrophy. The biotech, which is testing the compound in Phase IIb for diabetes, now hopes to find a partner for the new indication.

To read this article, you must be a SciBX subscriber through BioCentury. If you have subscribed to SciBX through our partner, Nature Publishing Group, please go to http://www.nature.com/scibx. Otherwise, please click below to contact us or start a free trial.

All contents Copyright © 1993-2013 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement and the BioCentury Terms of Use. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions at www.biocentury.com. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.

Read the Rest of this Article

Current Subscribers

If you are a current subscriber, log in below or in the upper right corner of this page.

Log In

UserID or email address

Password

Keep me logged in

Forgot password | Forgot Login

If you are a subscriber, but have forgotten or never received a password, please click above to receive a new one.

Purchase Options

Purchase this article for individual use

$30 USD
Purchase this article for limited one-time distribution and website posting

$750 USD

Subscription Option

Whether you want an individual subscription or need a global group license, we have the products, the experience and the customer support that biopharma executives, researchers, investors, service providers, and industry stakeholders have trusted for nearly two decades.

Let our Subscriber Services team customize the best intelligence package available in the industry to meet your needs.

SciBX: Science-Business eXchange

BioCentury's weekly translational science journal, published in collaboration with Nature Publishing Group:

Selects from hundreds of scientific papers published each week to identify early opportunities for investment, alliances and partnerships
Reports on the most commercially relevant developments

Subscribe Now

Get Free Trial